Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

PURPOSE: A non-randomised, open-label, Phase I safety and immunogenicity dose-finding study to assess the safety and immunogenicity of the candidate TB vaccine Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) from Mycobacterium tuberculosis (MTB) in healthy adult volunteers previously...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Pathan, Ansar A., Minassian, Angela M., Sander, Clare R., Rowland, Rosalind, Porter, David W., Poulton, Ian D., Hill, Adrian V.S., Fletcher, Helen A., McShane, Helen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Science 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3424417/
https://ncbi.nlm.nih.gov/pubmed/22789508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.06.084
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg